DiaSorin with a clear strategy focus, shares on the Milan listing

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 12:23.

DiaSorin (IT0003497168) is a long-established diagnostics specialist with its shares listed on Borsa Italiana in Milan. The company leans on a clear long-term strategy centered on specialty immunodiagnostics and molecular testing, in a competitive field that includes Roche and Abbott.

How DiaSorin positions itself

DiaSorin presents itself as a global player in in vitro diagnostics, with a focus on laboratory systems and reagent kits for immunodiagnostics and molecular diagnostics. Its portfolio spans infectious disease, oncology, endocrinology and cardiovascular testing, designed for hospital and private lab customers worldwide.

The group emphasizes recurring revenues from reagents used on installed instruments, aiming for stable cash generation and resilience across economic cycles. This recurring model is typical in diagnostics and mirrors approaches by peers such as Roche Diagnostics and Abbott Laboratories.

Long-term strategy and growth areas

DiaSorin’s long-term strategy highlights expanding its installed base of diagnostic instruments, which in turn drives reagent sales and supports predictable revenue streams over several years. The company targets both developed markets and select emerging regions with rising demand for laboratory testing.

Strategically, DiaSorin focuses on specialty testing segments where it can differentiate with proprietary assays, rather than competing purely on volume in broad commodity tests. This specialty focus seeks higher margins and closer relationships with clinical laboratories that value niche diagnostic panels.

The diagnostics products behind the stock

DiaSorin’s flagship solutions include the LIAISON family of automated immunodiagnostic analyzers, which run proprietary reagent kits for infectious diseases, endocrine disorders and other clinical indications. These instruments support high-throughput testing in hospital laboratories and independent diagnostic centers.

Where the shares trade today

DiaSorin shares (IT0003497168) trade on Borsa Italiana in Milan, where the stock is part of the Italian listed healthcare universe with prices quoted in euros.

Disclaimer: This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data are based on sources deemed reliable but cannot be guaranteed. Investors should conduct their own research and consult a qualified advisor before making investment decisions.